Handelsbanken Fonder Ab Roivant Sciences Ltd. Transaction History
Handelsbanken Fonder Ab
- $26.2 Billion
- Q4 2024
A detailed history of Handelsbanken Fonder Ab transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 113,109 shares of ROIV stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
113,109
Previous 191,409
40.91%
Holding current value
$1.19 Million
Previous $2.21 Million
39.43%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$694 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$655 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$504 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$465 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$373 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.43B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...